4D Molecular Therapeutics (FDMT) Total Current Liabilities (2019 - 2026)
4D Molecular Therapeutics (FDMT) posted Total Current Liabilities of $47.67 million for Q2 2026, up 37.5% from $34.68 million a year earlier and up 9.8% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Total Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, 4D Molecular Therapeutics' Total Current Liabilities came in at $43.99 million, up 50.9% from FY2024.
- Annual Total Current Liabilities has increased for three consecutive years, with a five-year compound annual growth rate of 21.3% (FY2020 to FY2025).
- In prior years, 4D Molecular Therapeutics' Total Current Liabilities was $29.15 million in FY2024 (+53.8%), $18.95 million in FY2023 (+20.5%), $15.73 million in FY2022 (-3.7%) and $16.34 million in FY2021 (-2.4%).
- The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q4 2019.
- On a year-over-year basis, Total Current Liabilities has increased in each of the last 12 quarters, with growth averaging 54.3% over the last eight quarters.
- The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2025, with growth of 78.7%; the weakest was Q1 2022, with a decline of 13.1%.
- According to Business Quant data, Total Current Liabilities for the three prior quarters was $43.4 million (Q1 2026), $43.99 million (Q4 2025) and $37.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -31.55 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 25.50 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.02 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 32.65 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.94 Bn |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -436.78 Mn | - | 47.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.67 Mn |
| Mar 31, 2026 | 43.40 Mn |
| Dec 31, 2025 | 43.99 Mn |
| Sep 30, 2025 | 37.11 Mn |
| Jun 30, 2025 | 34.68 Mn |
| Mar 31, 2025 | 26.90 Mn |
| Dec 31, 2024 | 29.15 Mn |
| Sep 30, 2024 | 29.47 Mn |
| Jun 30, 2024 | 19.40 Mn |
| Mar 31, 2024 | 16.40 Mn |
| Dec 31, 2023 | 18.95 Mn |
| Sep 30, 2023 | 18.16 Mn |
| Jun 30, 2023 | 13.75 Mn |
| Mar 31, 2023 | 11.28 Mn |
| Dec 31, 2022 | 15.73 Mn |
| Sep 30, 2022 | 13.56 Mn |
| Jun 30, 2022 | 14.33 Mn |
| Mar 31, 2022 | 12.09 Mn |
| Dec 31, 2021 | 16.34 Mn |
| Sep 30, 2021 | 11.37 Mn |
API Access
4D Molecular Therapeutics Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();